LIONHEAD(SH:600539) Zheng Quan Zhi Xing·2025-08-06 14:12Core Viewpoint - The company plans to acquire 97.4399% of Hangzhou Lipo Technology Co., Ltd. through a combination of issuing shares and cash payments, while also raising supporting funds through share issuance to specific companies [1]. Summary by Sections Impact on Earnings Per Share - The transaction is expected to increase the company's earnings per share (EPS) from 0.00 CNY/share to 0.01 CNY/share, reflecting an increase of 88.95% [3][4]. Measures to Mitigate Dilution Risk - The company will enhance its governance structure and risk management capabilities to improve operational efficiency post-transaction [4]. - It will optimize its profit distribution policy and investment return mechanisms to protect shareholder interests [5]. - The company has established performance commitments and compensation arrangements with the transaction parties to mitigate the risk of EPS dilution [5]. Commitments from Major Stakeholders - The controlling shareholders and management have made commitments to not interfere with the company's operations or infringe on its interests, ensuring adherence to the measures for mitigating dilution risk [5][6].